Abstract
Anxiety, obsessive-compulsive, and stress-related disorders frequently co-occur, and patients often present symptoms of several domains. Treatment involves the use of selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), but data on comparative efficacy and acceptability are lacking. We aimed to compare the efficacy of SSRIs, SNRIs, and placebo in multiple symptom domains in patients with these diagnoses over the lifespan through a 3-level network meta-analysis. We searched for published and unpublished randomized controlled trials that aimed to assess the efficacy of SSRIs or SNRIs in participants (adults and children) with diagnosis of any anxiety, obsessive-compulsive, or stress-related disorder in MEDLINE, PsycINFO, Embase, and Cochrane Library from inception to 23 April 2015, with an update on 11 November 2020. We supplemented electronic database searches with manual searches for published and unpublished randomized controlled trials registered in publicly accessible clinical trial registries and pharmaceutical companies' databases. No restriction was made regarding comorbidities with any other mental disorder, participants' age and sex, blinding of participants and r...Continue Reading
References
Jun 1, 1997·Journal of Clinical Epidemiology·H C BucherS D Walter
Jul 15, 1999·Psychological Medicine·J Van OsR Murray
Feb 28, 2001·The Psychiatric Clinics of North America·R Noyes
Dec 20, 2005·Journal of Clinical Epidemiology·Toshi A FurukawaNorio Watanabe
Sep 5, 2008·Journal of Affective Disorders·Alexander KonnopkaHans-Helmut König
Feb 3, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Stefan LeuchtJohn M Davis
Apr 24, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Tony Kendrick, Stephen Pilling
Mar 26, 2015·Contemporary Clinical Trials·Teresa GrecoGiovanni Landoni
Mar 26, 2015·JAMA Psychiatry·Annelieke M RoestErick H Turner
Apr 26, 2015·Journal of Affective Disorders·Yu HayasakaToshi A Furukawa
May 2, 2015·International Clinical Psychopharmacology·Borwin BandelowDirk Wedekind
Jun 2, 2015·Annals of Internal Medicine·Brian HuttonDavid Moher
Mar 1, 2011·Research Synthesis Methods·Spyros Konstantopoulos
Jun 1, 2012·Research Synthesis Methods·Georgia Salanti
Jun 13, 2016·Lancet·Andrea CiprianiPeng Xie
Jul 21, 2016·European Archives of Psychiatry and Clinical Neuroscience·Stefan LeuchtGeorgia Salanti
Oct 14, 2016·Lancet·UNKNOWN GBD 2015 Disease and Injury Incidence and Prevalence Collaborators
Oct 30, 2016·Epidemiology and Psychiatric Sciences·P CuijpersJ Twisk
Oct 30, 2016·Journal of Affective Disorders·Eiko I Fried
Apr 4, 2017·International Journal of Psychiatry in Clinical Practice·Michael BauerUNKNOWN WFSBP Task Force on Unipolar Depressive Disorders
Apr 7, 2017·JAMA : the Journal of the American Medical Association·Matthew E HirschtrittCarol A Mathews
May 10, 2017·Journal of Affective Disorders·Michael A SugarmanJonathan D Huppert
Aug 2, 2017·Comprehensive Psychiatry·Kelsie T ForbushSara R Gould
Jan 14, 2018·Evidence-based Mental Health·Taryn WilliamsJonathan Ipser
Jan 23, 2018·Depression and Anxiety·Jordi AlonsoUNKNOWN WHO World Mental Health Survey Collaborators
Feb 27, 2018·Lancet·Andrea CiprianiJohn R Geddes
Jul 22, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Gordon Parker
Dec 12, 2018·Journal of Clinical Epidemiology·Amit SaadGordon Guyatt
Feb 5, 2019·Lancet·April SleeNick Freemantle
Apr 30, 2019·JAMA Pediatrics·UNKNOWN GBD 2017 Child and Adolescent Health CollaboratorsNicholas J Kassebaum
Feb 6, 2020·Journal of Clinical Epidemiology·James C Hurley